Under-Display Camera Media Capture Patent

The European Patent Office published Samsung Electronics' patent EP4272458A1 for under-display camera technology, covering methods and electronic devices for capturing media through displays using AI-based image processing. The patent lists six inventors and includes multiple IPC classifications spanning H04N (image processing), G06N (AI/neural networks), and G06T (computer graphics).

Neural Network Compression Method and Apparatus Patent Application

The European Patent Office published Nokia Technologies Oy's patent application EP4323929A1 for a method, apparatus, and computer program product for neural network compression. The application covers techniques to reduce the computational and memory requirements of neural networks while maintaining performance. No compliance deadlines or regulatory actions are associated with this patent publication.

Immunogenic Composition Against Avian Influenza Virus H5 Subtype

The European Patent Office published patent application EP3876983A1 filed by Boehringer Ingelheim Vetmedica GmbH for an immunogenic composition against avian influenza virus H5 subtype. Inventors include Egbert Siegfried Mundt, Xiaoping Cui, and Zenglei Hu. The patent covers compositions classified under A61K 39/12 (viral vaccines) and is designated across all 44 EPO member states.

Solid Dispersions and Pharmaceutical Compositions Comprising Substituted Indane Compounds

The European Patent Office published patent EP3873443A1 for solid dispersions and pharmaceutical compositions comprising substituted indane compounds, assigned to Peloton Therapeutics, Inc. The patent covers formulation technologies for therapeutic applications with designation extending across EU member states and associated countries.

Icosapent Ethyl Patent for Cardiovascular Event Risk Reduction Methods

The European Patent Office published Patent EP3700518A1 for Amarin Pharmaceuticals Ireland Limited, covering methods of reducing cardiovascular event risk using icosapent ethyl compositions. The patent lists Paresh SONI as inventor and carries A61P classifications for cardiovascular treatments. The filing is designated across 31 European states including major markets such as Germany, France, and the United Kingdom.

Sustained-release pharmaceutical compositions comprising a sedative drug and uses thereof

The European Patent Office published patent application EP3849532A1 for sustained-release pharmaceutical compositions comprising sedative drugs and uses thereof. Applicants Taiwan Liposome Company, Ltd. and TLC Biopharmaceuticals, Inc. seek protection for liposomal formulations enabling controlled release of sedative agents. The published application covers designated contracting states AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR.

Nucleic Acid Complex Patent

The European Patent Office published patent application EP4032551A1 for a nucleic acid complex, filed by National University Corporation Tokyo Medical and Dental University and Takeda Pharmaceutical Company Limited. The patent covers therapeutic applications in neurological disorders (A61P 25/00) and related formulations. Pharmaceutical and biotechnology companies developing nucleic acid-based therapeutics should review this publication.

Scaleable Preparation of Polyketides

The European Patent Office published EP4009966A1, a patent application by The Regents of the University of California for a scaleable method of preparing polyketides. The invention lists Michael Burkart, Warren Chan, Brian Leon, James La Clair, and Kelsey Trieger as inventors, with applications including anti-neoplastic uses (A61P 35/02).

PCV2 Vaccine Patent - NDSU Research Foundation

The European Patent Office published EP4007601A2, a patent for a Porcine Circovirus Type 2 (PCV2) vaccine, granted to NDSU Research Foundation and Biological Mimetics, Inc. The patent covers vaccine compositions including live attenuated virus formulations and associated methods. Validated in 38 designated European states.

Immunotherapy Cell Patent - Memorial Sloan Kettering

The European Patent Office published patent application EP4007586A1 for Memorial Sloan Kettering Cancer Center, covering cells for improved immunotherapy and their uses. The patent designates multiple European states including DE, FR, GB, IT, NL, and others. This is a routine patent publication notice for a cancer immunotherapy technology developed by David A. Scheinberg and Leila Peraro.